Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Head & Neck 3Gastrointestinal 3Thoracic 2Other 2Lymphoid 2CNS 2Tumor-Agnostic 1Sarcoma 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1

Interventions

Paclitaxel 581Carboplatin 527Cisplatin 355Bevacizumab 256pembrolizumab 226Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 126Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 90niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 73Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 56Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pentoxifylline × Gynecologic × Clear all
NCT05231980 2023-07-20

Efficacy of Pentoxifylline and Alpha Lipoic Acid in PCOS Resistant to Clomiphene Citrate

Ain Shams University

Phase 2 Completed
120 enrolled
Gynecologic

Polycystic Ovary Syndrome, Primary Ovarian Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡